79 related articles for article (PubMed ID: 20552565)
1. Structure-activity relationship of marinostatin, a serine protease inhibitor isolated from a marine organism.
Taichi M; Yamazaki T; Kawahara K; Motooka D; Nakamura S; Harada S; Teshima T; Ohkubo T; Kobayashi Y; Nishiuchi Y
J Pept Sci; 2010 Jul; 16(7):329-36. PubMed ID: 20552565
[TBL] [Abstract][Full Text] [Related]
2. Solution structure of marinostatin, a natural ester-linked protein protease inhibitor.
Kanaori K; Kamei K; Taniguchi M; Koyama T; Yasui T; Takano R; Imada C; Tajima K; Hara S
Biochemistry; 2005 Feb; 44(7):2462-8. PubMed ID: 15709758
[TBL] [Abstract][Full Text] [Related]
3. Role of the backbone conformation at position 7 in the structure and activity of marinostatin, an ester-linked serine protease inhibitor.
Taichi M; Yamazaki T; Nishiuchi Y
Chembiochem; 2012 Sep; 13(13):1895-8. PubMed ID: 22851252
[TBL] [Abstract][Full Text] [Related]
4. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
5. The structural basis of a conserved P2 threonine in canonical serine proteinase inhibitors.
Brauer AB; Nievo M; McBride JD; Leatherbarrow RJ
J Biomol Struct Dyn; 2003 Apr; 20(5):645-56. PubMed ID: 12643767
[TBL] [Abstract][Full Text] [Related]
6. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
Orning L; Fischer PM; Hu CK; Agner E; Engebretsen M; Husbyn M; Petersen LB; Orvim U; Llinas M; Sakariassen KS
Thromb Haemost; 2002 Jan; 87(1):13-21. PubMed ID: 11848442
[TBL] [Abstract][Full Text] [Related]
7. Design of serine proteinase inhibitors by combinatorial chemistry using trypsin inhibitor SFTI-1 as a starting structure.
Zabłotna E; Jaśkiewicz A; Łegowska A; Miecznikowska H; Lesner A; Rolka K
J Pept Sci; 2007 Nov; 13(11):749-55. PubMed ID: 17828796
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
Xue F; Seto CT
Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
[TBL] [Abstract][Full Text] [Related]
9. Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.
Gunasekera SP; Miller MW; Kwan JC; Luesch H; Paul VJ
J Nat Prod; 2010 Mar; 73(3):459-62. PubMed ID: 20020755
[TBL] [Abstract][Full Text] [Related]
10. Introduction of alpha-hydroxymethyamino acid residues in substrate specificity P1 position of trypsin inhibitor SFTI-1 from sunflower seeds retains its activity.
Zabłotna E; Kret A; Jaśkiewicz A; Olma A; Leplawy MT; Rolka K
Biochem Biophys Res Commun; 2006 Feb; 340(3):823-8. PubMed ID: 16380077
[TBL] [Abstract][Full Text] [Related]
11. New cyanopeptide-derived low molecular weight inhibitors of trypsin-like serine proteases.
Radau G; Schermuly S; Fritsche A
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):300-9. PubMed ID: 12953218
[TBL] [Abstract][Full Text] [Related]
12. Relationship between temporary inhibition and structure of disulfide-linkage analogs of marinostatin, a natural ester-linked protein protease inhibitor.
Taniguchi M; Kamei K; Kanaori K; Koyama T; Yasui T; Takano R; Harada S; Tajima K; Imada C; Hara S
J Pept Res; 2005 Aug; 66(2):49-58. PubMed ID: 16000118
[TBL] [Abstract][Full Text] [Related]
13. Recognized sequence and conformation in design of linear peptides as a competitive inhibitor for HMG-CoA reductase.
Pak VV; Koo M; Yun L; Kwon DY
J Mol Recognit; 2007; 20(3):197-203. PubMed ID: 17486664
[TBL] [Abstract][Full Text] [Related]
14. The arginine mimicking β-amino acid β³hPhe(3-H₂N-CH₂) as S1 ligand in cyclotheonamide-based β-tryptase inhibitors.
Janke D; Sommerhoff CP; Schaschke N
Bioorg Med Chem; 2011 Dec; 19(23):7236-43. PubMed ID: 22047802
[TBL] [Abstract][Full Text] [Related]
15. Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.
Pakkala M; Hekim C; Soininen P; Leinonen J; Koistinen H; Weisell J; Stenman UH; Vepsäläinen J; Närvänen A
J Pept Sci; 2007 May; 13(5):348-53. PubMed ID: 17436344
[TBL] [Abstract][Full Text] [Related]
16. Computer based design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A serine protease inhibitors.
Ismail NS; El Dine RS; Hattori M; Takahashi K; Ihara M
Bioorg Med Chem; 2008 Sep; 16(17):7877-87. PubMed ID: 18752958
[TBL] [Abstract][Full Text] [Related]
17. Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moiety.
Malikayil JA; Burkhart JP; Schreuder HA; Broersma RJ; Tardif C; Kutcher LW; Mehdi S; Schatzman GL; Neises B; Peet NP
Biochemistry; 1997 Feb; 36(5):1034-40. PubMed ID: 9033393
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
[TBL] [Abstract][Full Text] [Related]
19. [Structure and function of marinostatin, a serine protease inhibitor].
Taichi M; Nishiuchi Y
Seikagaku; 2010 Nov; 82(11):1032-6. PubMed ID: 21226332
[No Abstract] [Full Text] [Related]
20. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
Lee DL; Hodges RS
Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
